AC Immune

Switzerland
Malters, Lucerne, Switzerland
+41 21 345 91 21 ★

Company profile

AC Immune company profile

AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials. The Company designs, discovers and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. AC Immune's two proprietary technology platforms create antibodies, small molecules and vaccines to address a broad spectrum of neurodegenerative indications

Business identity

Contact email
[email protected]
Phone number
+41 21 345 91 21
Operating status
Active
Company type
For Profit
Employee range
00101-00250 employees
Revenue range
$10K+
Founded
2003-01-01

Headquarters

Headquarters
Malters, Lucerne, Switzerland
Postal code
1015
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
5
Total equity funding
$167.5M
Last funding
Post Ipo Equity / $50M / 2023-12-15
Last equity funding
Post Ipo Equity / $50M
Investors
6
Lead investors
3
Founders
1
Articles
179
Exited on
2016-09-23

Founders and investors

Founders

Andrea Pfeifer

Lead investors

Biotechnology Value FundDietmar Hoppdievini Hopp Biotech Holding

Investors

Avidity PartnersBiotechnology Value Funddievini Hopp Biotech HoldingRedmile GroupStemPoint Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.